Bryan Johnson, a 46-year-old multimillionaire and self-proclaimed de-aging enthusiast, has garnered headlines once again for his controversial longevity experiments. Known for spending millions of dollars on his quest to reverse aging, Johnson recently revealed that he has stopped taking a once-promising de-aging drug, rapamycin, over concerns that it may have been accelerating his aging instead.
Johnson’s obsession with longevity began years ago after amassing wealth through successful tech ventures. His mission? To transform his biological age to that of a teenager. As part of his wellness routine, Johnson consumes 54 supplements daily, maintains a rigid exercise regimen, and follows a meticulously planned diet.
His endeavor to “break the world record in age reversal” includes heading a health and wellness startup called Blueprint, which markets itself as a longevity solutions company. Despite offering seemingly conventional health advice like exercising and eating healthily, Johnson’s personal experiments are far from ordinary.
Rapamycin: A Promising Start, A Disappointing End
Rapamycin, a drug originally developed to prevent organ rejection in transplant patients, has recently gained attention in longevity circles for its potential anti-aging properties. Johnson was one of its most vocal advocates, even describing his regimen as the “most aggressive rapamycin intake” in the industry.
However, after five years of using the drug, Johnson announced in November 2024 that he had discontinued it. “Despite the immense potential from pre-clinical trials, my team and I came to the conclusion that the benefits of lifelong dosing of rapamycin do not justify the hefty side effects,” Johnson tweeted.
These side effects included recurrent skin infections, elevated lipid and glucose levels, and an increased resting heart rate. Additionally, a new study published in late October indicated that rapamycin might accelerate aging across 16 epigenetic aging clocks. This revelation was enough for Johnson to abandon the drug altogether.
A History of Controversial Experiments
Johnson’s decision to discontinue rapamycin is not his first foray into the world of extreme anti-aging measures. His experiments have ranged from the bizarre to the unsettling.
One of his most controversial endeavors involved using his teenage son’s blood for transfusions, hoping to determine whether younger blood could reverse aging in older individuals. The results showed no significant benefits, and the practice was discontinued.
Recently, Johnson has also subjected himself to “shock treatments” on his genitals in an effort to reverse penile aging. This unconventional method aimed to restore the vigor of an 18-year-old but has not been scientifically validated.
These experiments have drawn widespread criticism, with many viewing them as reckless, unproven, and emblematic of the extremes to which the ultra-wealthy will go in pursuit of youth.
In addition to his personal experiments, Johnson founded Blueprint, a health startup promoting longevity. The company offers subscription-based “longevity mixes,” which are essentially protein powders marketed as anti-aging solutions. While the mixes contain beneficial ingredients, reviews have criticized them for being prohibitively expensive and not suitable for everyone.
Johnson’s website also promotes basic longevity advice—like avoiding smoking, limiting alcohol consumption, and exercising—raising questions about whether Blueprint offers anything groundbreaking or if it’s merely capitalizing on Johnson’s larger-than-life persona.
While Johnson’s efforts have certainly captured public attention, they underscore the risks of extreme self-experimentation. His once-average appearance has drastically changed, with Johnson himself admitting that he now resembles “a vampire.” This transformation has raised doubts about the effectiveness of his methods and whether they are doing more harm than good.
The broader scientific community remains skeptical of Johnson’s approach, emphasizing that most longevity breakthroughs are still in their infancy. Experts warn that relying on experimental drugs like rapamycin without extensive human trials can lead to unintended consequences, as Johnson’s experience illustrates.
Despite setbacks, Johnson shows no signs of giving up his quest to reverse aging. His relentless experimentation continues to push the boundaries of what’s possible—or ethical—in the realm of longevity science.
However, as Johnson’s case demonstrates, the pursuit of eternal youth may come at a steep cost, both physically and financially. While the allure of living longer drives innovation, it also raises important questions about the limits of science, the ethics of self-experimentation, and the role of wealth in accessing unproven treatments.
For now, the results of Johnson’s experiments remain inconclusive. What’s clear, however, is that his journey offers a cautionary tale about the challenges and potential pitfalls of trying to outsmart aging.
